Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.190
-0.070 (-5.56%)
At close: Apr 1, 2025, 4:00 PM
1.260
+0.070 (5.88%)
After-hours: Apr 1, 2025, 4:54 PM EDT

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $6.79 million. The enterprise value is $7.26 million.

Market Cap 6.79M
Enterprise Value 7.26M

Important Dates

The last earnings date was Monday, March 31, 2025, before market open.

Earnings Date Mar 31, 2025
Ex-Dividend Date n/a

Share Statistics

BCLI has 5.70 million shares outstanding. The number of shares has increased by 74.87% in one year.

Current Share Class 5.70M
Shares Outstanding 5.70M
Shares Change (YoY) +74.87%
Shares Change (QoQ) +7.50%
Owned by Insiders (%) 14.72%
Owned by Institutions (%) 7.23%
Float 4.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio -0.87
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio 0.04
Quick Ratio 0.03
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -151.86

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -241.99%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 163.63%
Revenue Per Employee n/a
Profits Per Employee -$400,793
Employee Count 29
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -85.95% in the last 52 weeks. The beta is 0.62, so BCLI's price volatility has been lower than the market average.

Beta (5Y) 0.62
52-Week Price Change -85.95%
50-Day Moving Average 1.69
200-Day Moving Average 2.97
Relative Strength Index (RSI) 28.71
Average Volume (20 Days) 34,139

Short Selling Information

The latest short interest is 122,765, so 2.15% of the outstanding shares have been sold short.

Short Interest 122,765
Short Previous Month 107,230
Short % of Shares Out 2.15%
Short % of Float 2.77%
Short Ratio (days to cover) 4.54

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -11.69M
Pretax Income -15.53M
Net Income -11.62M
EBITDA -11.44M
EBIT -11.69M
Earnings Per Share (EPS) -$2.31
Full Income Statement

Balance Sheet

The company has $187,000 in cash and $720,000 in debt, giving a net cash position of -$533,000 or -$0.09 per share.

Cash & Cash Equivalents 187,000
Total Debt 720,000
Net Cash -533,000
Net Cash Per Share -$0.09
Equity (Book Value) -7.76M
Book Value Per Share -1.26
Working Capital -8.59M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -74.87%
Shareholder Yield -74.87%
Earnings Yield -172.70%
FCF Yield n/a

Analyst Forecast

The average price target for BCLI is $30.00, which is 2,421.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target $30.00
Price Target Difference 2,421.01%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 18.01%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date Oct 1, 2024
Split Type Reverse
Split Ratio 0.0666667:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a